Neuropsychiatric Complications of Parkinson Disease Treatments: Importance of Multidisciplinary Care

Am J Geriatr Psychiatry. 2016 Dec;24(12):1171-1180. doi: 10.1016/j.jagp.2016.08.017. Epub 2016 Sep 3.

Abstract

Although Parkinson disease (PD) is defined clinically by its motor symptoms, it is increasingly recognized that much of the disability and worsened quality of life experienced by patients with PD is attributable to psychiatric symptoms. The authors describe a model of multidisciplinary care that enables these symptoms to be effectively managed. They describe neuropsychiatric complications of PD itself and pharmacologic and neurostimulation treatments for parkinsonian motor symptoms and discuss the management of these complications. Specifically, they describe the clinical associations between motor fluctuations and anxiety and depressive symptoms, the compulsive overuse of dopaminergic medications prescribed for motor symptoms (the dopamine dysregulation syndrome), and neuropsychiatric complications of these medications, including impulse control disorders, psychosis, and manic syndromes. Optimal management of these problems requires close collaboration across disciplines because of the potential for interactions among the pathophysiologic process of PD, motor symptoms, dopaminergic drugs, and psychiatric symptoms. The authors emphasize how their model of multidisciplinary care facilitates close collaboration among psychiatrists, other mental health professionals, neurologists, and functional neurosurgeons and how this facilitates effective care for patients who develop the specific neuropsychiatric complications discussed.

Keywords: anxiety; depression; dopamine replacement therapy (DRT); multidisciplinary care; neuropsychiatric (symptoms), nonmotor (symptoms); parkinson disease.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Antiparkinson Agents / adverse effects*
  • Antiparkinson Agents / therapeutic use
  • Anxiety / chemically induced
  • Anxiety / etiology
  • Depression / chemically induced
  • Depression / etiology
  • Disease Progression
  • Dopamine Agents / adverse effects
  • Dopamine Agents / therapeutic use
  • Humans
  • Interdisciplinary Communication*
  • Mental Disorders / chemically induced
  • Mental Disorders / etiology*
  • Models, Theoretical
  • Motor Neuron Disease / chemically induced
  • Motor Neuron Disease / etiology
  • Motor Neuron Disease / psychology
  • Parkinson Disease / complications*
  • Parkinson Disease / drug therapy
  • Parkinson Disease / psychology
  • Patient Care Team

Substances

  • Antiparkinson Agents
  • Dopamine Agents